Collegium Pharmaceutical (COLL) Other Non Operating Income (2014 - 2025)
Collegium Pharmaceutical's (COLL) quarterly Other Non Operating Income came in at -$16.0 million in Q4 2025, down 285.86% quarter-over-quarter from -$4.1 million in Q3 2024.
Collegium Pharmaceutical (COLL) Other Non Operating Income (2014 - 2025) Analysis & Trends
Collegium Pharmaceutical's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$16.0 million for Q4 2025.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$16.0 million in Q4 2025; TTM through Dec 2025 was -$16.0 million, a 41.18% decrease from a year earlier, with the FY2025 full-year figure at -$16.0 million, down 41.18% from the prior year.
- Other Non Operating Income retreated to -$16.0 million in Q4 2025 per COLL's latest filing, from -$4.1 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $23.5 million in Q1 2023 and bottomed at -$47.0 million in Q2 2023.
- The 3-year median for Other Non Operating Income is -$7.2 million (2024), against an average of -$10.2 million.
- Biggest YoY gain for Other Non Operating Income was 84.72% in 2024; the steepest drop was 84.72% in 2024.
- Year by year, Other Non Operating Income stood at -$47.0 million in 2023, then soared by 91.18% to -$4.1 million in 2024, then plunged by 285.86% to -$16.0 million in 2025.
- Per Business Quant, the three latest COLL Other Non Operating Income figures stand at -$16.0 million (Q4 2025), -$4.1 million (Q3 2024), and -$7.2 million (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.99 Mn |
| Sep 30, 2024 | -4.15 Mn |
| Jun 30, 2024 | -7.18 Mn |
| Jun 30, 2023 | -47.01 Mn |
| Mar 31, 2023 | 23.50 Mn |
| Dec 31, 2017 | 180,000.00 |
| Sep 30, 2017 | 167,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Mar 31, 2017 | 98,000.00 |
| Dec 31, 2016 | 20,000.00 |
| Sep 30, 2016 | -2,000.00 |
| Jun 30, 2016 | -46,000.00 |
| Mar 31, 2016 | -66,000.00 |
| Dec 31, 2015 | -89,000.00 |
| Sep 30, 2015 | -97,000.00 |
| Jun 30, 2015 | -99,000.00 |
| Mar 31, 2015 | 91,000.00 |
| Dec 31, 2014 | -142,000.00 |
| Sep 30, 2014 | -51,000.00 |
| Jun 30, 2014 | -29,000.00 |